Total planned funding: $1,032,951,036
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $275,129,893 |
Ethiopia | $148,793,133 |
Uganda | $96,555,936 |
Zambia | $95,336,729 |
Mozambique | $65,704,313 |
South Africa | $48,238,194 |
Tanzania | $47,835,261 |
Nigeria | $35,797,738 |
Rwanda | $27,454,358 |
Malawi | $22,328,858 |
Botswana | $22,241,913 |
Democratic Republic of the Congo | $20,354,128 |
Vietnam | $16,966,592 |
Lesotho | $15,896,321 |
Côte d'Ivoire | $14,376,922 |
Haiti | $12,857,000 |
Dominican Republic | $10,776,000 |
Ghana | $10,706,612 |
South Sudan | $10,203,000 |
Cambodia | $9,116,500 |
Indonesia | $7,217,000 |
Eswatini | $6,166,001 |
Namibia | $2,915,630 |
Guyana | $2,534,400 |
Ukraine | $2,260,056 |
Russia | $1,900,000 |
Zimbabwe | $1,090,000 |
Angola | $600,000 |
India | $565,948 |
China | $536,400 |
Thailand | $496,200 |
Program Areas
Treatment | $324,011,233 |
Care | $235,319,646 |
Prevention | $228,866,397 |
Governance and Systems | $143,564,017 |
Testing | $60,636,174 |
Budget Codes
HTXD: Treatment: ARV Drugs | $203,860,526 |
HTXS: Treatment: Adult Treatment | $111,188,307 |
HBHC: Care: Adult Care and Support | $105,639,510 |
HKID: Care: Orphans and Vulnerable Children | $102,172,099 |
HVOP: Sexual Prevention: Other Sexual Prevention | $94,717,931 |
OHSS: Health Systems Strengthening | $71,351,786 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $62,436,976 |
HVCT: Testing: HIV Testing and Counseling | $60,636,174 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $55,514,000 |
HVSI: Strategic Information | $48,474,758 |
HLAB: Laboratory Infrastructure | $23,737,473 |
HVTB: Care: TB/HIV | $21,322,620 |
PDTX: Treatment: Pediatric Treatment | $8,962,400 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,403,655 |
PDCS: Care: Pediatric Care and Support | $6,185,417 |
HMIN: Biomedical Prevention: Injection Safety | $4,112,500 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,810,000 |
HMBL: Biomedical Prevention: Blood Safety | $1,871,335 |